The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
SEM reiterates that earnings for 2025 are likely to be between $1.09 and $1.19 per share.
Select Medical Holdings Corporation (NYSE:SEM ) Q1 2025 Earnings Conference Call May 2, 2025 9:00 AM ET Company Participants Robert Ortenzio - Executive Chairman and Co-Founder Martin Jackson - Senior Executive Vice President of Strategic Finance and Operations Conference Call Participants Justin Bowers - Deutsche Bank Ben Hendrix - RBC Capital Markets William Sutherland - The Benchmark Company Ann Hynes - Mizuho Operator Good morning, and thank you for joining us today for Select Medical Holdings Corporation's Earnings Conference Call to discuss the first quarter 2025 results at the company's -- and the company's business outlook. Presenting today are the company's Executive Chairman and Co-Founder, Robert Ortenzio; and the company's Senior Executive Vice President of Strategic Finance and Operations, Martin Jackson.
Select Medical (SEM) came out with quarterly earnings of $0.44 per share, missing the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.77 per share a year ago.
SEM expects revenues to be between $5.4 billion and $5.6 billion, the mid-point of which implies 5.8% growth from the 2024 figure of $5.2 billion.
Select Medical Holdings Corporation (NYSE:SEM ) Q4 2024 Earnings Conference Call February 21, 2025 9:00 AM ET Company Participants Robert Ortenzio - Executive Chairman and Co-Founder Martin Jackson - Senior Executive Vice President of Strategic Finance and Operations Michael Malatesta - Executive Vice President and CFO Conference Call Participants Justin Bowers - Deutsche Bank Ben Hendricks - RBC Capital Markets Joanna Gajuk - Bank of America Operator Good morning, and thank you for joining us today for Select Medical Holdings Corporation's Earnings Conference Call to discuss the Fourth Quarter and Full Year 2024 Results and the Company's Business Outlook. Speaking today are the Company's Executive Chairman and Co-Founder, Robert Ortenzio; the Company's Senior Executive Vice President of Strategic Finance and Operations, Martin Jackson; and Executive Vice President and CFO, Michael Malatesta.
Select Medical (SEM) came out with quarterly earnings of $0.18 per share, missing the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.36 per share a year ago.
Rising expenses and high leverage are impacting Select Medical's prospects.
Select Medical (SEM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
The heavy selling pressure might have exhausted for Select Medical (SEM) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
By separating from Concentra, which specializes in occupational health services, SEM can better allocate resources to its primary segments.